GlycoNAVI Proteins

GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.

Source Last Updated
GlycoNAVI Proteins December 11, 2024
Displaying entries 20801 - 20850 of 40384 in total
PDB ID UniProt ID Title ▼ Descriptor
6MSS P11609 Diversity in the type II Natural Killer T cell receptor repertoire and antigen specificity leads to differing CD1d docking strategies
6MSS P01887 Diversity in the type II Natural Killer T cell receptor repertoire and antigen specificity leads to differing CD1d docking strategies
3AZS Q9X273 Diverse Substrates Recognition Mechanism Revealed by Thermotoga maritima Cel5A Structures in Complex with Mannotriose
3AZT Q9X273 Diverse Substrates Recognition Mechanism Revealed by Thermotoga maritima Cel5A Structures in Complex with Cellotetraose
3AZR Q9X273 Diverse Substrates Recognition Mechanism Revealed by Thermotoga maritima Cel5A Structures in Complex with Cellobiose
5L6N P00734 Disulfated madanin-thrombin complex
5L6N Q86FP9 Disulfated madanin-thrombin complex
6XR8 P0DTC2 Distinct conformational states of SARS-CoV-2 spike protein
6XRA P0DTC2 Distinct conformational states of SARS-CoV-2 spike protein
7A92 P0DTC2 Dissociated S1 domain of SARS-CoV-2 Spike bound to ACE2 (Unmasked Refinement)
7A92 Q9BYF1 Dissociated S1 domain of SARS-CoV-2 Spike bound to ACE2 (Unmasked Refinement)
7A91 P0DTC2 Dissociated S1 domain of SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement)
7A91 Q9BYF1 Dissociated S1 domain of SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement)
7R12 P0DTC2 Dissociated S1 domain of Mink Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement)
7R12 Q9BYF1 Dissociated S1 domain of Mink Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement)
7R11 P0DTC2 Dissociated S1 domain of Beta Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement)
7R11 Q9BYF1 Dissociated S1 domain of Beta Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement)
7R0Z P0DTC2 Dissociated S1 domain of Alpha Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement)
7R0Z Q9BYF1 Dissociated S1 domain of Alpha Variant SARS-CoV-2 Spike bound to ACE2 (Non-Uniform Refinement)
7R10 P0DTC2 Dissociated S1 domain of Alpha Variant SARS-CoV-2 Spike bound to ACE2
7R10 Q9BYF1 Dissociated S1 domain of Alpha Variant SARS-CoV-2 Spike bound to ACE2
5CPS Q9LV91 Disproportionating enzyme 1 from Arabidopsis - maltotriose soak
5CQ1 Q9LV91 Disproportionating enzyme 1 from Arabidopsis - cycloamylose soak
5CPT Q9LV91 Disproportionating enzyme 1 from Arabidopsis - beta cyclodextrin soak
5CSU Q9LV91 Disproportionating enzyme 1 from Arabidopsis - acarviostatin soak
5CSY Q9LV91 Disproportionating enzyme 1 from Arabidopsis - acarbose soak
5NES A0A069Q9V4 Discovery, crystal structures and atomic force microscopy study of thioether ligated D,L-cyclic antimicrobial peptides against multidrug resistant Pseudomonas aeruginosa
5NES 5NES Discovery, crystal structures and atomic force microscopy study of thioether ligated D,L-cyclic antimicrobial peptides against multidrug resistant Pseudomonas aeruginosa
5NEY A0A069Q9V4 Discovery, crystal structures and atomic force microscopy study of thioether ligated D,L-cyclic antimicrobial peptides against multidrug resistant Pseudomonas aeruginosa
5NEY 5NEY Discovery, crystal structures and atomic force microscopy study of thioether ligated D,L-cyclic antimicrobial peptides against multidrug resistant Pseudomonas aeruginosa
5NF0 A0A069Q9V4 Discovery, crystal structures and atomic force microscopy study of thioether ligated D,L-cyclic antimicrobial peptides against multidrug resistant Pseudomonas aeruginosa
5NF0 5NF0 Discovery, crystal structures and atomic force microscopy study of thioether ligated D,L-cyclic antimicrobial peptides against multidrug resistant Pseudomonas aeruginosa
5BQH O14684 Discovery of a Potent and Selective mPGES-1 Inhibitor for the Treatment of Pain
5BQI O14684 Discovery of a Potent and Selective mPGES-1 Inhibitor for the Treatment of Pain
5KOQ P00797 Discovery of TAK-272: A Novel, Potent and Orally Active Renin In-hibitor
5KOS P00797 Discovery of TAK-272: A Novel, Potent and Orally Active Renin In-hibitor
5KOT P00797 Discovery of TAK-272: A Novel, Potent and Orally Active Renin In-hibitor
3PDF P53634 Discovery of Novel Cyanamide-Based Inhibitors of Cathepsin C
6ZJZ Q9NR97 Discovery of M5049: a novel selective TLR7/8 inhibitor for treatment of autoimmunity
4CZS C0HJY1 Discovery of Glycomimetic Ligands via Genetically-encoded Library of Phage displaying Mannose-peptides
4CZS 4CZS Discovery of Glycomimetic Ligands via Genetically-encoded Library of Phage displaying Mannose-peptides
4RCH P35557 Discovery of 2-Pyridyl Ureas as Glucokinase Activators
5K5E P06276 Discovery and Structure-Activity Relationships of a Highly Selective Butyrylcholinesterase Inhibitor by Structure-Based Virtual Screening
3IJ7 P04746 Directed 'in situ' Elongation as a Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic Intermediate of Human Pancreatic a-Amylase
3IJ8 P04746 Directed 'in situ' Elongation as a Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic Intermediate of Human Pancreatic a-Amylase
3IJ9 P04746 Directed 'in situ' Elongation as a Strategy to Characterize the Covalent Glycosyl-Enzyme Catalytic Intermediate of Human Pancreatic a-Amylase
6EL4 B9W4V6 Direct-evolutioned unspecific peroxygenase from Agrocybe aegerita, in complex with veratryl alcohol
6EL0 B9W4V6 Direct-evolutioned unspecific peroxygenase from Agrocybe aegerita, in complex with styrene
6EKZ B9W4V6 Direct-evolutioned unspecific peroxygenase from Agrocybe aegerita, in complex with propranolol
6EKW B9W4V6 Direct-evolutioned unspecific peroxygenase from Agrocybe aegerita, in complex with naphthalene

About Release Notes Help Feedback

International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.1.0

Last updated: December 9, 2024